ConditionPsoriasis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorSouth Valley University
About this trial
Psoriasis is a skin disorder that is chronic proliferative and inflammatory in nature. Extensor surfaces, scalp, and lumbosacral area are covered in erythematous plaques with silvery scales. The disease can also impair the eyes and joints. It has no cure. Because of their low quality of life, many psoriasis patients experience depression. In addition to the cutaneous manifestations, it is associated with an increased risk of psoriatic arthritis, depression and cardiovascular disease.
Eligibility criteria
Qualifiers
None
Disqualifiers
Patients with other autoimmune or inflammatory conditions (e.g., rheumatoid arthritis, lupus).
Pregnancy and lactation.
Patients currently undergoing any treatment other than Humira.
Patients with known genetic disorders affect immune system function.
Trial design
Treatments tested in this trial
- Humira
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov